These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 3030325)
41. [Comparative study of the mechanism of inhibition of Sindbis virus reproduction by adamantane derivatives: remantadine and amide of 1-adamantane carboxylic acid]. Andronova VL Antibiot Khimioter; 1996; 41(7-8):26-30. PubMed ID: 8999758 [TBL] [Abstract][Full Text] [Related]
42. Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults. Hayden FG; Gwaltney JM; Van de Castle RL; Adams KF; Giordani B Antimicrob Agents Chemother; 1981 Feb; 19(2):226-33. PubMed ID: 7347558 [TBL] [Abstract][Full Text] [Related]
43. Evaluation of antiviral substances against influenza A virus strains by the haemadsorption reduction test. Heider H; Adamczyk B; Richter B Acta Virol; 1980 Sep; 24(5):373-6. PubMed ID: 6108069 [TBL] [Abstract][Full Text] [Related]
44. Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults. Hayden FG; Minocha A; Spyker DA; Hoffman HE Antimicrob Agents Chemother; 1985 Aug; 28(2):216-21. PubMed ID: 3834831 [TBL] [Abstract][Full Text] [Related]
45. Design and synthesis of 1,2-annulated adamantane piperidines with anti-influenza virus activity. Zoidis G; Kolocouris N; Naesens L; De Clercq E Bioorg Med Chem; 2009 Feb; 17(4):1534-41. PubMed ID: 19195900 [TBL] [Abstract][Full Text] [Related]
46. Combined antiinfluenza activity of a plant preparation SHS-174 and amantadine derivatives. Serkedjieva J; Zgorniak-Nowosielska I Acta Virol; 1993 Aug; 37(4):258-64. PubMed ID: 7905240 [TBL] [Abstract][Full Text] [Related]
47. Amantadine and rimantadine have no direct inhibitory effects against hepatitis C viral protease, helicase, ATPase, polymerase, and internal ribosomal entry site-mediated translation. Jubin R; Murray MG; Howe AY; Butkiewicz N; Hong Z; Lau JY J Infect Dis; 2000 Jan; 181(1):331-4. PubMed ID: 10608783 [TBL] [Abstract][Full Text] [Related]
48. Metabolic profiling to evaluate the impact of amantadine and rimantadine on the secondary metabolism of a model organism. Kostina-Bednarz M; PÅ‚onka J; Barchanska H Sci Rep; 2023 Oct; 13(1):16822. PubMed ID: 37798340 [TBL] [Abstract][Full Text] [Related]
50. Stereoselective synthesis of novel adamantane derivatives with high potency against rimantadine-resistant influenza A virus strains. Kuznetsov NY; Tikhov RM; Godovikov IA; Medvedev MG; Lyssenko KA; Burtseva EI; Kirillova ES; Bubnov YN Org Biomol Chem; 2017 Apr; 15(15):3152-3157. PubMed ID: 28338150 [TBL] [Abstract][Full Text] [Related]
51. Investigation of the free energy profiles of amantadine and rimantadine in the AM2 binding pocket. Van Nguyen H; Nguyen HT; Le LT Eur Biophys J; 2016 Jan; 45(1):63-70. PubMed ID: 26391902 [TBL] [Abstract][Full Text] [Related]
52. Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokinetics. Hayden FG; Hoffman HE; Spyker DA Antimicrob Agents Chemother; 1983 Mar; 23(3):458-64. PubMed ID: 6847173 [TBL] [Abstract][Full Text] [Related]
53. Rimantadine: a clinical perspective. Wintermeyer SM; Nahata MC Ann Pharmacother; 1995 Mar; 29(3):299-310. PubMed ID: 7606077 [TBL] [Abstract][Full Text] [Related]
54. [Amantadine and rimantadine against influenza A]. Bruu AL; Orstavik I Tidsskr Nor Laegeforen; 1992 Jun; 112(16):2102-4. PubMed ID: 1523633 [TBL] [Abstract][Full Text] [Related]
55. Insights from investigating the interactions of adamantane-based drugs with the M2 proton channel from the H1N1 swine virus. Wang JF; Wei DQ; Chou KC Biochem Biophys Res Commun; 2009 Oct; 388(2):413-7. PubMed ID: 19665993 [TBL] [Abstract][Full Text] [Related]
56. Amantadine and rimantadine for the prevention of influenza A. Betts RF Semin Respir Infect; 1989 Dec; 4(4):304-10. PubMed ID: 2697053 [TBL] [Abstract][Full Text] [Related]
57. Low incidence of rimantadine resistance in field isolates of influenza A viruses. Ziegler T; Hemphill ML; Ziegler ML; Perez-Oronoz G; Klimov AI; Hampson AW; Regnery HL; Cox NJ J Infect Dis; 1999 Oct; 180(4):935-9. PubMed ID: 10479115 [TBL] [Abstract][Full Text] [Related]
58. Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Englund JA; Champlin RE; Wyde PR; Kantarjian H; Atmar RL; Tarrand J; Yousuf H; Regnery H; Klimov AI; Cox NJ; Whimbey E Clin Infect Dis; 1998 Jun; 26(6):1418-24. PubMed ID: 9636873 [TBL] [Abstract][Full Text] [Related]
59. [Chemoprophylaxis and chemotherapy of influenza with rimantadine]. Zlydnikov DM; Kubar' OI; Kovaleva TP Vopr Virusol; 1981; (5):516-24. PubMed ID: 7039118 [No Abstract] [Full Text] [Related]
60. [Radioactive labeling by means of tritium atomic beam of some antivirus preparations]. Tul'kes SG; Shishkov AV; Pravdina NF; Galegov GA Biofizika; 1981; 26(3):529-30. PubMed ID: 7260167 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]